课题基金 / 基金详情

Cellular immune response against HBV nucleocapsid antigen

Cellular immune response against HBV nucleocapsid antigen
针对 HBV 核衣壳抗原的细胞免疫反应
批准号:
07457593
负责人:
KAKUMU Shinichi
金额:
$0.83万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

KAKUMU Shinichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is generally believed that HLA class I restricted cytotoxic T lymphocytes (CTL) play an important role in hepatocellular injury during acute and chronic HBV infection. Recent studies have also suggested that hepatitis B virus (HBV) core region could be an immunological target. We established HBcAg-specific CTL from peripheral blood mononuclear cells (PBMC) or liver-infiltrating lymphocytes (LIL) of patients with chronic HBV infection using selected five synthetic peptides. PBMC were obtained from 10 patients with chronic HBV infection. Five clones from PBMC and one clone from LIL displayd a cytotoxic respones (more than 10%). We concluded that HLA class I restricted CTL that recognize HBcAg are present among PBMC and LIL of patients with chronic HBV infection. In successive study, we examined the change of nucleotide esquence of a part of core region at 3 points (before, top, and after the exacerbation) in the time course of hepatitis B infection, and compared the diversity of amino acids. 6 chronic HBV carriers who experienced the exacerbation of their disease were selected and nt 2062-2364 (303bp) were sequenced from the sera. The mean substitution rate were higher in the second sera than in the first (4 out of 6 patients), and lower in the third sera than in the second (4 out of 6patients). No significant difference was found in the rate of deduced amino acid divergence for the ideal HLA-A2 binding motifs between patients bearing HLA-A2 and not bearing it. Although no specific amino acid substitution in respect to HLA-A2 was found, some amino acid tends to be substituted at high frequency. We are now investigating the effect of HBV mutant on the function of helper T lymphocytes. We believe that these results could lead us to the developemt of vaccine therapy against HBV infection.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Iwata K.: "Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection." Hepatology. 22. 1057-1064 (1995)
Iwata K.:“在慢性丙型肝炎感染中,外周血淋巴细胞向丙型肝炎病毒核心蛋白产生干扰素γ。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
奥村明彦 他.: "HBV core領域中央部に対する抗体反応の解析" 日本肝臓学会総会. (発表予定).
Akihiko Okumura 等人:“对 HBV 核心区域中央区域的抗体反应分析”日本肝脏研究学会全体会议(待提交)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Luca G.Guidotti et al.: "Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes" Immunity. 4. 25-36 (1996)
Luca G.Guidotti 等人:“细胞毒性 T 淋巴细胞对乙型肝炎病毒进行细胞内灭活”免疫。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Identification and clinical application for the role of NKT cells in patients with chronic hepatitis and hepatocellualr carcinoma infected hepatitis virus
  • 批准号:
    15390236
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.09万
  • 财政年份:
    2003
  • 负责人:
    KAKUMU Shinichi
  • 依托单位:
To clarify the mechanism of chronicity and to explore therapeutic approach for viral hepatitis
  • 批准号:
    12670529
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2000
  • 负责人:
    KAKUMU Shinichi
  • 依托单位:
Pathologicl significance and its inhibition of apoptosis on the development and its progression of liver injury.
  • 批准号:
    10470142
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 资助金额:
    $8.45万
  • 财政年份:
    1998
  • 负责人:
    KAKUMU Shinichi
  • 依托单位:
IMMUNO-PATHOGENESIS AND-THERAPY OF VIRAL HEPATITIS
  • 批准号:
    09044341
  • 项目类别:
    Grant-in-Aid for international Scientific Research
  • 资助金额:
    $2.24万
  • 财政年份:
    1997
  • 负责人:
    KAKUMU Shinichi
  • 依托单位:
国内基金
海外基金
基于PBMC单细胞测序和多色流式细胞术鉴定的中国荷斯坦牛一般抗病性标志CD4+CD8+DP T细胞发育分化及功能机制研究
  • 批准号:
    32372847
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    杨章平
  • 依托单位:
attIL12-PBMC 治疗前列腺癌骨转移的机制研究
  • 批准号:
    82373071
  • 项目类别:
    面上项目
  • 资助金额:
    48万元
  • 批准年份:
    2023
  • 负责人:
    杨清
  • 依托单位:
PBMC中TLR9/MyD88通路激活诱导免疫稳态失衡在精神压力促进寻常型银屑病发生发展中的机制研究
  • 批准号:
    --
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    33万元
  • 批准年份:
    2022
  • 负责人:
    宋秋荷
  • 依托单位:
单细胞转录组测序鉴定高血压相关的PBMC亚群及关键分子
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    张欢
  • 依托单位: